Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of patients with lung cancer.
|Videos|June 12, 2019
Dr. Anna F. Farago New Cytotoxic Strategies for Relapsed Small-Cell Lung Cancer
Author(s)Anna F. Farago, MD, PhD
Advertisement
Cancer Network spoke with Anna F. Farago, MD, medical oncologist at Massachusetts General, about recent research presented at ASCO 2019 on the efficacy of new cytotoxic strategies compared with chemotherapy for the treatment of relapsed small-cell lung cancer patients.
Advertisement
Related to this article
Medical oncologists, clinical pharmacists, and oncologic nurse practitioners share the presentation topics to look out for at WCLC 2026.
The interim 3-year OS rates were 71.2% with OST-HER2 vs 45.8% in historical controls in a phase 2b trial of fully resected, pulmonary metastatic osteosarcoma.
Advertisement
Advertisement
Trending on CancerNetwork
1
CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma
2
Neoantigen Vaccine Shows Encouraging Activity in Head and Neck Cancer
3
What Were the Key Hematologic Oncology Takeaways from SOHO 2026?
4
COA Warns That Price Negotiation for Medicare Part B Drugs Threatens Community Oncology
5